CClinicalTrials.gg
CompletedNCT04752995Updated Feb 12, 2021

Proximal Tibial Osteotomy Osteoclasis In Infantile Genu-Varum

An interventional study of osteotomy in Deformity Knee and Deformity of Limb, sponsored by Tanta University. Completed. Open to participants aged 36 Months to 52 Months. Per ClinicalTrials.gov, last updated 2021-02-12.

Sponsored by Tanta University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 8 years 1 month after the study started (first participant enrolled Jan 2013, registered Feb 2021).
Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Not applicable
Ages
36 Months to 52 Months
Sex
All
01

Study summary

Genu-varum is a common problem encountered in pediatric orthopedic. Correction of pathological deformity is mandatory to ensure normal load transfer through the knee. In this study, the investigators describe a new technique of osteotomy osteoclasis in order to evaluate if it is an effective and reliable method in management of infantile genu varum

Read the detailed description

Seventy children with 122 legs suffering significant infantile genu-varum were treated by percutaneous osteotomy-osteoclasis technique. The mean age was 46 months. Genu varum was bilateral in 52 children and unilateral in 18 with a mean preoperative proximal medial tibial angle 66.67 ± 2.670. Under general anesthesia, transverse osteotomy osteoclasis was performed below the tibial tuberosity. Follow-up radiograph was done within the first post-operative week and then every two weeks to assess alignment and consolidation.

02

Conditions studied

  • Deformity Knee
  • Deformity of Limb

Keywords

  • Genu varum, mini-invasive, osteotomy, osteoclasis
03

In context

Genu Varum

20 studies on the registry are indexed under Genu Varum; 9 are open to participants now.

This study's enrollment of 70 is above the median of 56 across 14 interventional studies indexed under Genu Varum.

Browse Genu Varum studies →

Lead sponsor

Tanta University is the lead sponsor of 963 studies on the registry; 304 are open to participants now.

Of its 16 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
36 Months to 52 Months
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Infantile genu-varum
  • PMTA≤70 not spontaneously corrected

Exclusion criteria

Exclusion criteria:

  • Active rickets or other metabolic disease
  • Patients in whom the femur or the joint is the main site of the deformity
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
70 participants (actual)

Study arms

  • Other
    high tibial osteotomy

    Under general anesthesia, a one-cm vertical skin incision was done at the medial subcutaneous border of the tibia, one fingerbreadth below the tibial tuberosity. This was confirmed by intra-operative C-arm images. Longitudinal periosteal incision was done with minimal dissection. Incomplete medial transverse osteotomy including both anterior and posterior cortex was performed using drill bit or small thin osteotome.Osteotomy was completed manually by osteoclasis of the lateral cortex to provide postoperative stability by the preserved lateral periosteum. No fibular osteotomy was needed in the present study.

    Procedure: osteotomy

Interventions

  • Procedureosteotomy

    osteotomy osteoclasis of upper tibia

06

What researchers measure

Primary outcomes

  1. proximal medial tibial angle

    This angle was used for assessment of degree of deformity correction and to follow the presence of under- or over-correction

    Time frame: one year

  2. the posterior proximal tibial angle

    confirm the absence or presence of any sagittal pro or recurvatum deformities(normal=81±2 degrees)

    Time frame: one year

  3. Self-Administered Patient Satisfaction Scale

    the investigators asked the parents to rate their satisfaction on a scale from zero to 100 (100 to 75 very satisfied, \<75 to 50 somewhat satisfied, \<50 to 25 somewhat dissatisfied and \<25 dissatisfied).Those who were not satisfied are requested to explain the cause of dissatisfaction.

    Time frame: one year

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Rab GT. Oblique tibial osteotomy revisited. J Child Orthop. 2010 Apr;4(2):169-72. doi: 10.1007/s11832-009-0228-z. Epub 2009 Dec 20. PubMed 20234769 ↗

Individual participant data

Plan to share: No — the investigators will publish the final results

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 12, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04752995
Lead sponsor
Tanta University
Responsible party
ahmed m. samy (assisstant professor, Tanta University) — Principal investigator
First posted
Feb 12, 2021
Start date
Jan 2013
Primary completion
Jul 2015
Completion
Jan 2016
Last update
Feb 12, 2021

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion